| Name | DC_517 | 
|---|---|
| Synonyms | 1-{[1,3-Di(9H-carbazol-9-yl)-2-propanyl]oxy}-3-(isopropylamino)-2-propanol 2-Propanol, 1-[2-(9H-carbazol-9-yl)-1-(9H-carbazol-9-ylmethyl)ethoxy]-3-[(1-methylethyl)amino]- | 
| Description | DC_517 is a DNA methyltransferase 1 (DNMT1) inhibitor, with an IC50 and a Kd of 1.7 μM and 0.91 μM, respectively. | 
|---|---|
| Related Catalog | |
| Target | DNMT1:0.91 μM (Kd) DNMT1:1.7 μM (IC50) | 
| In Vitro | DC_517 is a DNA methyltransferase 1 (DNMT1) inhibitor, with an IC50 and a Kd of 1.7 μM and 0.91 μM, respectively. DC_517 (1.25, 2.5, 5, and 10 μM) potently inhibits the proliferation of HCT116 (human colon cancer) and Capan-1 (human pancreatic adenocarcinoma cells) after treatment for 24, 48, and 72 h. DC_517 (0, 0.75, 1.5, and 3 μM) also dose-dependently induces apoptotic cell death in HCT116 cells[1]. | 
| Kinase Assay | To measure the effects of DC_517 on mouse DNMT1 activity, 200 nM purified DNMT1 is incubated with 200 μM of DC_517 and S-adenosylmethionine (AdoMet) in the DNMT assay buffer in the assay plate at 37°C for 2 h. Next, every sample is incubated with the capture and detection antibody, followed by incubation with developer solution for 10 min at room temperature. The absorbance is measured at 450 nm using a microplate reader. S-Adenosylhomocysteine (AdoHcy) is used as a positive control[1]. | 
| References | 
| Density | 1.2±0.1 g/cm3 | 
|---|---|
| Boiling Point | 727.9±60.0 °C at 760 mmHg | 
| Molecular Formula | C33H35N3O2 | 
| Molecular Weight | 505.650 | 
| Flash Point | 394.0±32.9 °C | 
| Exact Mass | 505.272919 | 
| LogP | 8.26 | 
| Vapour Pressure | 0.0±2.5 mmHg at 25°C | 
| Index of Refraction | 1.644 | 
| Storage condition | 2-8℃ |